Nebula Research & Development LLC Tandem Diabetes Care Inc Call Options Transaction History
Nebula Research & Development LLC
- $618 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TNDM
# of Institutions
348Shares Held
72.9MCall Options Held
3.12MPut Options Held
343K-
Black Rock Inc. New York, NY11.1MShares$360 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.38MShares$239 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA3.67MShares$119 Million0.02% of portfolio
-
State Street Corp Boston, MA2.57MShares$83.2 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.5MShares$81.1 Million1.33% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $2.08B
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...